Inceptor Bio

Recent Finacing

Series A

Recent Raise

$37M

Inceptor Bio, a Morrisville biotechnology developer of CAR-T, CAR-M, and CAR-NK therapies, employs M83 co-stimulatory domain, TMax manufacturing, K62 macrophage platform, iPSC tech and GMP manufacturing.

Founded 2020

North Carolina, United States

11-50

Private

inceptor.bio

Highlights

Focus Areas

Biotechnology

Health Care

Wellness

Recent Investors

Financials

$37M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Inceptor Bio.